Medtronic Tells Investors Its ICD Market Share Is Recovering
This article was originally published in The Gray Sheet
Executive Summary
Medtronic believes its share of the implantable cardioverter defibrillator (ICD) market is stabilizing after withstanding challenges from Boston Scientific and St. Jude